Pediatric practices could make significant improvements to their developmental surveillance and screening processes in a short time. This project team’s initiative shows just how quickly your practice can, too.
For Contemporary Pediatrics, Dr Bobby Lazzara discusses the latest data on the effectiveness of CAR T-cell therapy from the ELIANA trial, which was presented at the 2018 American Society of Hematology annual meeting in San Diego, California.
ADVERTISEMENT
This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.
This email was sent by: %%Member_Busname%% %%Member_Addr%%
%%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%